Bio-Technological Innovation and Need for Patent Protection

Patents provide legal protection for inventions, whether they are products or processes, allowing the patent holder to restrict others from making, using, or selling the invention without authorization. Essentially, a patent grants the inventor exclusive rights to create or utilize their invention for a specific period. Once this period expires, the invention enters the public domain and can be freely used by anyone. Patents fall under the broader category of intellectual property and can be transferred or licensed to others for commercial gain. Traditionally, patents for living organisms were rare, largely due to scientific limitations and legal complexities. Until the 1980s, life forms were seldom patented, as most patent systems struggled to classify biological entities. Later, in 2001, the Court reaffirmed this stance, extending patentability to plants. This shift in legal perspective prompted deeper discussions about whether products derived from nature are genuine inventions or merely discoveries. Courts have since been tasked with discerning whether biological innovations result from human ingenuity or are simply natural phenomena. Biotechnology has evolved rapidly, expanding from traditional fields like plant and animal breeding to advanced technologies like recombinant DNA, protoplast fusion, and cloning. While breakthroughs such as mammalian cloning highlight the field's progress, claims of human cloning raise significant ethical and legal concerns, marking a controversial frontier in bioscience.